The liver is very often the first and most significant site of neuroendocrine tumor metastasis and for many people, managing the disease in the liver is the most challenging part of their NET journey. In this episode of NETWise, we’re going to focus on an organ that is almost never a NET primary site, but nevertheless is crucially important to many people with NETs: the liver. 

First, you’ll learn that the liver is a unique organ with a resiliency that is remarkable. Why is the liver such a frequent site for NET metastases?   Hear about the various treatments for liver neuroendocrine tumors and the risks and benefits of each of them. 

Cindy Lovelace and Katherine Mueller share their experiences, the treatments they have had for their liver NETs, and their advice for other patients.  

Dr. Mary Maluccio
Surgical Oncologist
Medical Director
Louisiana State University/Ochsner Medical Center NET Program

Dr. Satya Das 
Medical Oncologist
Co-Director, Neuroendocrine Tumor Program
Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center

Dr. Helen Te
Clinical Hepatologist
University of Chicago Medical Center

Dr. Xavier Keutgen
Director of the Neuroendocrine Tumor Center 
University of Chicago Medical Center

Dr. Osman Ahmed
Interventional Radiologist
University of Chicago Medical Center

Special thanks to Cindy Lovelace and Katherine Mueller for sharing their stories.  This episode is dedicated to Katherine’s memory.  We thank her family for their support of her inclusion in this podcast.

2021 KNOW YOUR NETS: Keeping your Liver Healthy

2020 KNOW YOUR NETS: How Much Can Liver Take – Treating with IR

2020 KNOW YOUR NETS: NETs Surgery: Risks and Benefits for Metastatic Tumors

Request a Mailed Copy of our Neuroendocrine Cancer Guide

Information and Resources for the Newly Diagnosed

NETRF YouTube Channel

The post NETWise Episode 17: Focus on Liver NETs appeared first on NETRF.